Clinical trials of GLP-1 and dual-agonist medications report average percentage body-weight changes that vary by drug, dose, duration, and population. Individual results range from modest to substantial — and some people stop early due to side effects or cost.
What clinics emphasize instead of guarantees
- Eligibility and contraindications first
- Titration pace and GI tolerance
- Protein and resistance training to protect muscle
- Plan for maintenance after dose changes
After stopping GLP-1 · GLP-1 nutrition · Evaluation service.
Non-scale wins
Waist, labs, mobility, apnea symptoms, and energy often matter as much as the number on the scale. Track with your clinician.
Free clinic callback
Partner clinics follow up. Free for patients. Educational site only.
Educational only. Not medical advice or diagnosis. Licensed clinicians decide care. Results vary.